2009 Fiscal Year Final Research Report
Analysis of 24-hydroxycholesterol as a biomarker of Alzheimer's disease and target of the medicine for Alzheimer's disease.
| Project/Area Number |
19790142
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Medical pharmacy
|
|---|
| Research Institution | Nigata University of Phermacy and Applied Life Sciences |
|---|
Principal Investigator |
NAKAGAWA Saori Nigata University of Phermacy and Applied Life Sciences, 薬学部, 助教 (30410228)
|
|---|
| Project Period (FY) |
2007 – 2009
|
| Keywords | 24S-ヒドロキシコレステロール / アルツハイマー病 / 細胞毒性 |
|---|
| Research Abstract |
A simple pretreatment method for the determination of 24S-hydroxycholesterol as a surrogate marker of Alzheimer disease in human plasma and human cerebrospinal fluid by gas chromatography/mass spectrometry (GC/MS) has been developed. It was found a tendency that the concentration levels of 24S-hydroxycholesterol and amyroid・in plasma with Lewy patients have been decreased. Futhermore, we investigate 24S-hydroxycholesterol-mediated cytotoxicity for SH-SY5Y cells, and also explore the anti-cytotoxicity agents. We found the polyphenols from Japanese tea have an anti-cytotoxicitic effect.
|
Research Products
(38 results)
